TXMD vs. APM, BFRG, GDTC, RNXT, LSTA, FBRX, CPIX, ITRM, BNTC, and ONCT
Should you be buying TherapeuticsMD stock or one of its competitors? The main competitors of TherapeuticsMD include Aptorum Group (APM), Bullfrog AI (BFRG), CytoMed Therapeutics (GDTC), RenovoRx (RNXT), Lisata Therapeutics (LSTA), Forte Biosciences (FBRX), Cumberland Pharmaceuticals (CPIX), Iterum Therapeutics (ITRM), Benitec Biopharma (BNTC), and Oncternal Therapeutics (ONCT). These companies are all part of the "pharmaceutical preparations" industry.
TherapeuticsMD (NASDAQ:TXMD) and Aptorum Group (NASDAQ:APM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, community ranking and media sentiment.
TherapeuticsMD received 345 more outperform votes than Aptorum Group when rated by MarketBeat users. However, 68.33% of users gave Aptorum Group an outperform vote while only 62.36% of users gave TherapeuticsMD an outperform vote.
In the previous week, TherapeuticsMD had 4 more articles in the media than Aptorum Group. MarketBeat recorded 4 mentions for TherapeuticsMD and 0 mentions for Aptorum Group. TherapeuticsMD's average media sentiment score of 0.34 beat Aptorum Group's score of 0.00 indicating that TherapeuticsMD is being referred to more favorably in the media.
30.7% of TherapeuticsMD shares are held by institutional investors. Comparatively, 3.8% of Aptorum Group shares are held by institutional investors. 1.2% of TherapeuticsMD shares are held by company insiders. Comparatively, 64.0% of Aptorum Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
TherapeuticsMD has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, Aptorum Group has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500.
Aptorum Group has lower revenue, but higher earnings than TherapeuticsMD.
Aptorum Group's return on equity of 0.00% beat TherapeuticsMD's return on equity.
Summary
TherapeuticsMD and Aptorum Group tied by winning 6 of the 12 factors compared between the two stocks.
Get TherapeuticsMD News Delivered to You Automatically
Sign up to receive the latest news and ratings for TXMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TXMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
TherapeuticsMD Competitors List
Related Companies and Tools
